Bottom line
What is AZNIX's expense ratio?
AZNIX's expense ratio is 0.89%, or about $89 a year on every $10,000 invested. That is more expensive than 52% of large growth funds we track (median 0.87%). It has no front-end sales load.
Updated Oct 22, 2026
AZNIX fee table
| Net expense ratio | 0.89% |
|---|---|
| Gross expense ratio | 0.89% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.24% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 22, 2026
What AZNIX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| AZNIX | $91 | $284 | $493 | $1,096 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.89% expense ratio costs roughly $49,800 in lost growth, versus about $48,700 for the median large growth fund (0.87%).